全文获取类型
收费全文 | 1154454篇 |
免费 | 82118篇 |
国内免费 | 2309篇 |
专业分类
耳鼻咽喉 | 15476篇 |
儿科学 | 30129篇 |
妇产科学 | 27487篇 |
基础医学 | 160777篇 |
口腔科学 | 32492篇 |
临床医学 | 103899篇 |
内科学 | 230160篇 |
皮肤病学 | 22322篇 |
神经病学 | 94451篇 |
特种医学 | 46409篇 |
外国民族医学 | 94篇 |
外科学 | 186747篇 |
综合类 | 20577篇 |
现状与发展 | 2篇 |
一般理论 | 407篇 |
预防医学 | 78108篇 |
眼科学 | 26612篇 |
药学 | 87514篇 |
4篇 | |
中国医学 | 2459篇 |
肿瘤学 | 72755篇 |
出版年
2021年 | 10538篇 |
2019年 | 10627篇 |
2018年 | 14570篇 |
2017年 | 11181篇 |
2016年 | 12334篇 |
2015年 | 14211篇 |
2014年 | 19796篇 |
2013年 | 28060篇 |
2012年 | 40170篇 |
2011年 | 41903篇 |
2010年 | 24388篇 |
2009年 | 23037篇 |
2008年 | 39498篇 |
2007年 | 41353篇 |
2006年 | 41790篇 |
2005年 | 40584篇 |
2004年 | 38852篇 |
2003年 | 36687篇 |
2002年 | 35655篇 |
2001年 | 56765篇 |
2000年 | 58113篇 |
1999年 | 49028篇 |
1998年 | 13411篇 |
1997年 | 11632篇 |
1996年 | 11473篇 |
1995年 | 10624篇 |
1994年 | 9755篇 |
1993年 | 9042篇 |
1992年 | 36580篇 |
1991年 | 34974篇 |
1990年 | 33625篇 |
1989年 | 32692篇 |
1988年 | 29749篇 |
1987年 | 28947篇 |
1986年 | 27020篇 |
1985年 | 25908篇 |
1984年 | 18771篇 |
1983年 | 15975篇 |
1982年 | 8824篇 |
1979年 | 16305篇 |
1978年 | 11143篇 |
1977年 | 9514篇 |
1976年 | 8329篇 |
1975年 | 8967篇 |
1974年 | 10807篇 |
1973年 | 10168篇 |
1972年 | 9590篇 |
1971年 | 9055篇 |
1970年 | 8581篇 |
1969年 | 8034篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
2.
Kamolz Lars-Peter Kotzbeck Petra Schintler Michael Spendel Stephan 《European Surgery》2022,54(3):163-169
European Surgery - Large skin defects caused by trauma (e.g., burns) or due to other reasons (e.g., tumor-related skin resections) require sufficient skin replacement. The constant improvement of... 相似文献
3.
4.
5.
6.
7.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
8.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
9.
10.
Daniel Schar Pawin Padungtod Nguyen Tung Michael OLeary Wantanee Kalpravidh Filip Claes 《Influenza and other respiratory viruses》2019,13(6):618-621
Among the chief limitations in achieving early detection and control of animal‐origin influenza of pandemic potential in high‐risk livestock populations is the existing lag time between sample collection and diagnostic result. Advances in molecular diagnostics are permitting deployment of affordable, rapid, highly sensitive, and specific point‐of‐capture assays, providing opportunities for targeted surveillance driving containment strategies with potentially compelling returns on investment. Interrupting disease transmission at source holds promise of disrupting cycles of animal‐origin influenza incursion to endemicity and limiting impact on animal production, food security, and public health. Adoption of new point‐of‐capture diagnostics should be undertaken in the context of promoting robust veterinary services systems and parallel support for operationalizing pre‐authorized plans and communication strategies that will ensure that the full potential of these new platforms is realized. 相似文献